Objective. We present a technical protocol for rigorous assessment of patient-reported outcomes and psychophysical testing relevant to lumbar sympathetic blocks for the treatment of postamputation pain (PAP). This description is intended to inform future prospective investigation.
Introduction
Postamputation pain (PAP) is ubiquitous among amputees and is often a prominent aspect of disability and decreased quality of life [1] [2] [3] [4] . PAP includes both phantom limb pain (PLP) and residual limb pain (RLP). PLP is the perception of painful sensations in the absent portion of an amputated limb. RLP refers to pain within the intact portion of the amputated limb, which might occur either simultaneously or independent of PLP. It is estimated that 60-80% of all patients will experience PAP after traumatic or nontraumatic limb amputations, with 10-15% of patients going on to develop severe persistent PAP [5] .
Growing understanding of the pathophysiologic mechanisms involved in PAP suggests at least a partial contribution from ectopic activity at the residual limb neuroma. These neuroma may be potent pain generators, may drive central plasticity and sensitization, and thus may ultimately lead to an increased sympathetic tone via the central drive of the midbrain structures [6] . This sympathetic dysfunction hypothetically has direct, measurable, and negative effects on residual limb tissue-through the mechanisms of increased efferent sympathetic tone, increased stimulation of pathologic neuroma noradrenergic receptors, and relative hypoxia with decreased tissue oxygenation and nutrition-and these physiologic changes can be (hypothetically) prime movers/mediators of increased pain [6, 7] . As such, prevention of neuroma formation is a surgical goal [8] , and this structure has garnered interest as a target of pain treatments via injection, neuromodulation, neurolysis, or surgical excision [9] [10] [11] [12] [13] .
Alternatively, proximal modulation of the sympathetic nervous system at the level of the sympathetic ganglia represents a distinct method of influencing this dysfunctional circuitry that hypothetically contributes to PAP. However, while blockade of such pathways has an established role in a subset of patients with a variety of conditions [14] [15] [16] [17] [18] [19] [20] , there has been a paucity of investigation of this technique for the management of PAP. Pilot data suggest that a subset of patients with PAP experience clinically significant improvement in pain symptoms for up to two months following lumbar sympathetic block (LSB) [21] , yet no other outcome literature has been published. Further high-quality study is needed to determine if LSB is indeed a useful treatment option for patients with PAP, and if so, what factors may predict a successful treatment response. Here, we present a technical protocol for rigorous assessment of patient-reported outcomes and psychophysical testing relevant to lumbar sympathetic blocks for the treatment of PAP. This description is intended to inform future prospective investigation.
Methods
The below-described participants were extracted from a larger cohort of patients enrolled in the Pathophysiology of Post-Amputation Pain study funded by the Department of Defense, US Army Medical Research and Material Command (USAMRMC), which was approved by the Northwestern University Institutional Review Board. Participants were recruited at the Rehabilitation Institute of Chicago and Northwestern Memorial Hospital. All participants signed a written informed consent form for study participation. In order to be included, individuals (1) were at least 18 years of age, (2) had a single lower limb traumatic or nontraumatic amputation, and (3) went on to develop PAP of at least 3/10 in intensity on the numerical rating scale (NRS) (4) lasting at least three months.
At the initial visit, baseline pain characteristics were assessed on a numerical rating scale as well as by psychometric testing using the McGill Pain QuestionnaireShort Form (MPQ-SF) [22] , Center for Epidemiological Studies Depression Scale (CES-D 10) [23] , Pain and Anxiety Symptoms Scale-short version (PASS-20) [24] , and Pain Disability Index (PDI) [25] . Psychophysical and biometric testing was also performed, which included vibration sensation testing, pinprick sensation testing (hyperalgesia), brush sensation testing (hypoesthesia, allodynia), Von Frey repeated weighted pinprick sensation (mechanical wind-up), thermal quantitative sensory testing (tQST; warm sensation, cold sensation, hot pain, cold pain), and square wave electrical stimulation (15-50 mA for 0.1 ms) with infrared telethermography. On the second visit, subjects were randomized to receive either a sympathetic nerve block with bupivacaine or dry needling to the lumbar sympathetic ganglion. All psychometric, psychophysical, and biometric testing measures previously given during the first visit were repeated following the injection and pre/post numerical rating scores (NRS) and MPQ-VAS measurements were obtained assessing PLP and RLP. The subjects were then brought back at four to six weeks for follow-up, where testing was repeated a third time. Of note, a functional MRI (fMRI) was obtained at the second visit prior to and following the injections; however, these data and the infrared telethermography data will not be included in this paper. A schematic presentation of the study timeline is shown in Figure 1 .
Outcome Measurement

Psychometric Measurements
McGill Pain Questionnaire-Short Form. The MPQ-SF is a well-validated pain measure that includes a numeric/ descriptor scale that can be subdivided into Sensory and Affective pain descriptors, and a 100-mm visual analog scale (VAS) [22] .
Pain and Anxiety Symptoms Scale. The PASS-20 is a 20-item, well-validated measure of anxiety in pain patients (e.g., #3 "I go immediately to bed when I feel severe pain" and #19 "I worry when I am in pain"). Each item is rated "never" to "always" on a scale from 0 to 5 [24] .
Center for Epidemiologic Studies Short Depression Scale. The validated index of depression used in this study, the CES-D 10 consists of 10 items covering ways people might have felt or behaved during the past week. Each item is rated "rarely or none of the time" to "most or all of the time." Two items denote positive affect (i.e., #5 "I felt hopeful about the future" and #8 "I was happy"); the remaining items denote negative affect (e.g., #6 "I felt fearful" and #9 "I felt lonely") [23] .
Pain Disability Index. The extent to which pain interferes with normal activities is measured for this study by the PDI. Each of the seven items refers to activities in the realms of family/home responsibilities, recreation, social activity, occupation, sexual behavior, self-care, and lifesupport activity (e.g., eating, sleeping). Each item is rated from "no disability" to "total disability" on a scale from 0 to 10. It provides a total disability score [25] .
Psychophysical Measurements
All the afferent stimulation was applied on the distal part of the residual limb. A verbal NRS pain scale score was queried during tests of pain sensation (0-10, "no pain" to "worst pain imaginable").
Vibration, weighted pin, and camel hair brush testing light touch (large and small myelinated fibers) were tested using a Von Frey Hair to determine the least perceptible stimulus. NRS scores were queried following vibration testing on a bony prominence with a RydelSeiffer tuning fork and following stimulus using a #1,500 camel hair brush. Pain transmitted via A-delta fibers was assessed by NRS score following stimulation with a 256-mN weighted pin. After the first NRS verbal rating, the pin touch simulation was repeated with stimulation of one stimulation per second for 10 seconds to search for a wind-up effect on these small myelinated fibers [26] [27] [28] .
Quantitative Sensory Testing. Temperature perception and temperature pain threshold (small unmyelinated and small myelinated fibers) were assessed with the standard "limits" program for the Medoc quantitative sensory testing device using establish protocols [29] [30] [31] [26] [27] [28] . QST has been shown in class II and III studies to be "probably or possibly" useful in identifying small-or large-fiber sensory abnormalities in patients with diabetic neuropathy, small-fiber neuropathies, uremic neuropathies, and demyelinating neuropathy [32] .
Procedure Technique
Lumbar Sympathetic Block
Participants were positioned prone on a fluoroscopy table, and the lumbar spine region was prepared with chlorhexidine and draped in a sterile fashion. Fluoroscopy was used to identify the L2 anterior margin of the L2 vertebral body in an oblique view. After injection of 1-2 mL of 1% lidocaine into the skin and subcutaneous tissues, a lumbar sympathetic block was accomplished by inserting a 22-gauge, seven-inch spinal needle in this planned oblique trajectory in which the transverse process was aligned with the vertebral body. The needle was advanced to the target point 1-3 mm proximal to the anterolateral margin of the L2 vertebral body. Once needle position was deemed appropriate using anterior-posterior and lateral imaging, 2-4 mL of radiopaque contrast dye was injected to ensure adequate spread to the relevant spinal levels, T12-L4, and the absence of intravascular uptake under live fluoroscopic observation (Figure 2) . When an appropriate contrast pattern was established and vascular uptake was ruled out, 10 mL of 0.25% preservative-free bupivacaine was incrementally injected. The effectiveness of the block was confirmed by comparing the preinjection with postinjection temperature of the distal limb using a disposable surface temperature probe.
Sham Injection/Dry Needling
This injection was performed using an identical technique to that described above for lumbar sympathetic block, except that no local anesthetic was injected following contrast deposition. Instead, small needle movements of 2-4-mm amplitude were performed at the targeted area. 
Results
Case Descriptions
Participant 1
Participant 1 was a 57-year-old man with a right transfemoral amputation secondary to peripheral vascular disease resulting in a four-year history of residual limb pain and phantom limb pain of the same duration, which he described as stabbing/sawing sensations that were most notable with prolonged sitting, weight bearing, weather changes, and removing his prosthetic device. A lumbar sympathetic block was performed as described above. Complete results are shown in Tables 1-4 .
Participant 2
Subject 2 was a 61-year-old man, with a right transfemoral amputation secondary to peripheral vascular disease and a resulting two-year history of phantom limb and residual limb pain. His residual limb pain was episodic, occurring at least once a day, lasting for minutes at a time before remitting, and it was described as mostly throbbing and aching, most noticeable with improper donning of his prosthesis. His phantom limb pain was more constant and nonremitting, burning and electric shock-like in nature, without alleviating factors. A sham lumbar sympathetic block was performed as described above. Complete results are shown in Tables 1-4 .
Participant 3
Participant 3 was a 49-year-old woman with a left transtibial amputation due to injuries sustained from blunt force trauma with 26 years of resulting phantom limb and residual limb pain. Her residual limb pain was described as intermittent, sharp, and throbbing with associated allodynia and hyperalgesia; the phantom limb pain was described as throbbing, cramping, and aching with associated numbness and tingling in the absent portion of the lower limb. A sham lumbar sympathetic block was performed as described above. Complete results are shown in Tables 1-4 .
Participant 4
Participant 4 was a 28-year-old man with a right transtibial amputation due to blunt force trauma resulting in a four-year history of phantom limb pain and residual limb pain. He experienced daily, unremitting residual limb pain, exacerbated by walking and wearing his prosthesis. A lumbar sympathetic block was performed as described above. Complete results are shown in Tables 1-4 .
Discussion
There has long been speculation that sympathetic activity may be involved in the generation of pain in amputees [6] . Hypothetical mechanisms for this include noradrenergic or other sympathetic nervous system transmitters, stimulation of pathological receptors on the neuroma [33] , and the development of a regional pain phenomena similar to complex regional pain syndrome in the residual limb [6] . None of the hypotheses has been properly tested to date. In this small case series, treatment of PAP with a single lumbar sympathetic block resulted in reduction of both residual limb pain and phantom limb pain as well as perceived disability on the PDI at short-term follow-up, while such was not the case for the two participants who were randomized 
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to receive the sham intervention. All participants, regardless of group assignment, showed improved perception of light touch threshold on Von Frey Hair testing. Likewise, all participants reported lower depression scores on the CES-D 10, and either improvement or no change in pain-related anxiety on the PASS-20 at short-term follow-up. Taken in isolation, this case series represents proof of concept/feasibility that a role may exist for lumbar sympathetic block for the treatment of PAP.
Interestingly, both participants who received the sham intervention reported clinically significant reduction in pain on the NRS immediately postinjection; however, these effects were transient in nature compared with the subjects who received a lumbar sympathetic block with bupivacaine. Our sham group included patients who received dry needling to the target ganglion as opposed to the local introduction of inert solutions of saline or dextrose, other commonly used placebos. Dry needling has been well described in the treatment of myofascial trigger points, with some central mechanisms purported [34] ; however, this has not been studied in the context of neural blockade of sympathetic ganglia, and thus it is unclear why these subjects reported immediate relief postinjection. Contrast injection might also theoretically serve as an active placebo. However, statistical aberration given the small sample size is the most likely explanation until proven otherwise.
In the single paper to directly address sympathetic blocks and PAP and residual limb pain, Cohen et al. report that "sympathetic mechanisms play a role in PLP and to a lesser extent, RLP, but that blocks confer long-term benefits in only a small percentage of patients" [21] . There has long been speculation that sympathetic activity causes or maintains pain in a subset of subjects with PAP [35, 36, 7, 6] . What is needed now is good prospective research into this question as sympathetic abnormality is easy to detect (physical exam, infrared telethermography) and manipulate (as in this manuscript) to study the impact of the synmpatetic nervous system on causing, exacerbating, or maintaining pain in amputees.
As to methodology for studying this question, we have used and recommend the validated procedures endorsed by the German Pain Network, as above [26, 27] . Psychometrics should include subjective pain measures such as the NRS as well as a consideration of more qualitative pain testing such as the McGill Pain Questionnaire-Short Form version II [22] . In the protocol presented, an inclusion criterion of an NRS score greater or equal to three was used; however, future studies might appropriately use a minimum NRS score of four as a criterion, which is common in the interventional pain literature. Our preliminary results suggest an association between autonomic dysfunction and anxiety and depression [6, 7] , and thus we suggest measuring anxiety, for instance, with the PASS [24] and depression using such instruments as the CES-D. Physical examination techniques such as vibration sensation testing, pinprick sensation testing (hyperalgesia), and brush sensation testing (hypoesthesia, allodynia) should be supplemented by quantitative testing such as the psychophysical measurement of temperature perception, pain perception, and pain tolerance using standard and validated instruments. These may also be supplemented by biometric testing such as infrared telethermography, which can objectively measure temperature asymmetry. Notably, in a future study, investigators may consider measuring distal limb surface temperature immediately pre-and post-LSB in order to confirm appropriate sympathetic blockade, but also, measurement of this temperature change may be considered in the sham group in order to determine if dry needling or another sham intervention results in similar physiologic effects.
Conclusion
In this small case series, treatment of PAP with a single lumbar sympathetic block but not sham intervention resulted in reduction of both residual limb pain and phantom limb pain as well as perceived disability on the PDI at three-month follow-up. We propose a robust methodology for the assessment of pain and other psychometric and psychophysical elements of PAP. An appropriately powered randomized controlled study using this methodology may not only aid in determining the possible clinical efficacy of lumbar sympathetic block in PAP, but could also improve our understanding of underlying pathophysiologic mechanisms of PAP.
